Literature DB >> 12015462

Meningococcal disease: how to prevent and how to manage.

Paul Balmer1, Elizabeth Miller.   

Abstract

Meningococcal disease is a significant problem in the paediatric population. The diagnosis of meningococcal disease can be problematic and progression of the disease can rapidly lead to a life-threatening illness. Despite the success of antibiotic treatment, mortality rates remain high. The development of protein-polysaccharide conjugate vaccines has significantly improved the success of vaccination in reducing the incidence of meningococcal disease. However, a comprehensive vaccine conferring protection against disease-associated serogroups remains elusive. The aim of this review is to highlight recent significant improvements in the prevention and management of meningococcal disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12015462     DOI: 10.1097/00001432-200206000-00010

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  4 in total

Review 1.  Genotypic characterization of Neisseria meningitidis using Pyrosequencing.

Authors:  Matthew A Diggle; Stuart C Clarke
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

2.  Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria.

Authors:  Margret Y Richter; Håvard Jakobsen; Alda Birgisdottir; Jean-François Haeuw; Ultan F Power; Giuseppe Del Giudice; Antonella Bartoloni; Ingileif Jonsdottir
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Epidemics of meningococcal meningitis in Northern Nigeria focus on preventive measures.

Authors:  Salisu Abdullahi Balarabe
Journal:  Ann Afr Med       Date:  2018 Oct-Dec

4.  A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana.

Authors:  Abraham Hodgson; Abudulai Adams Forgor; Daniel Chandramohan; Zarifah Reed; Fred Binka; Cornelia Bevilacqua; Dominique Boutriau; Brian Greenwood
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.